Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Background/aims Demyelination and axonal degeneration are the hallmarks of established white matter lesions (WML). The neurochemistry of ongoing WML is only partially known. We explored cerebrospinal fluid (CSF) substances as markers of brain tissue damage in relation to progression of WML rated on magnetic resonance imaging. Methods CSF from elderly individuals with WML was analyzed for amyloid markers, total τ, hyperphosphorylated τ, neurofilament protein light subunit, sulfatide and CSF/serum-albumin ratio. After 3 years, a follow-up magnetic resonance imaging was performed. Progression of WML was rated using the Rotterdam Progression Scale (RPS). Results 37 subjects (age 73.6 ± 4.6 years) were included. Subjects with more pronounced progression (RPS > 2; n = 15) had lower mean sulfatide concentration at baseline as compared to subjects with no or minimal progression (RPS 0-2; n = 22) according to univariate analyses (p = 0.009). Sulfatide was the only biomarker that predicted the RPS score according to regression analysis, explaining 18.9% of the total variance (r = 0.38, p = 0.015). Conclusion The correlation of CSF sulfatide levels and RPS scores may reflect a remyelination response to the demyelination process associated with WML. Furthermore, the results strengthen the notion that WML pathology is different from that of Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Attempts to remyelinate are present in the damaged white matter in leukoaraiosis (Jonsson et al., 2012).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Jonsson et al., 2012
Citations
Cites
Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living
Lawton, M. P., & Brody, E. M. (1969) · The Gerontologist · doi:10.1093/geront/9.3_part_1.179 · Cited by 18,540
MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging
Fazekas, F., Chawluk, J., Alavi, A., Hurtig, H., & Zimmerman, R. (1987) · American Journal of Roentgenology · doi:10.2214/ajr.149.2.351 · Cited by 5,334
Pantoni, L. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70104-6 · Cited by 3,405
Self-citationA New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT
Wahlund, L. O., Barkhof, F., Fazekas, F., Bronge, L., Augustin, M., Sjögren, M., Wallin, A., Ader, H., Leys, D., Pantoni, L., et al. (2001) · Stroke · doi:10.1161/01.str.32.6.1318 · Cited by 1,797
Self-citationSubcortical ischaemic vascular dementia
Román, G. C., Erkinjuntti, T., Wallin, A., Pantoni, L., & Chui, H. C. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00190-4 · Cited by 1,067
Self-citationTibbling, G., Link, H., & Ohman, S. (1977) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365517709091496 · Cited by 966
Tibbling, G., Link, H., & Ohman, S. (1977) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365517709091496 · Cited by 813
Hachinski, V. C., Potter, P., & Merskey, H. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520130013009 · Cited by 755
Rosengren, L. E., Karlsson, J., Karlsson, J., Persson, L. I., & Wikkelsø, C. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67052013.x · Cited by 499
Longstreth, W. T., Arnold, A. M., Beauchamp, N. J., Manolio, T. A., Lefkowitz, D., Jungreis, C., Hirsch, C. H., O’Leary, D. H., & Furberg, C. D. (2005) · Stroke · doi:10.1161/01.str.0000149625.99732.69 · Cited by 474
Cited by
The Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
“Attempts to remyelinate are present in the damaged white matter in leukoaraiosis (Jonsson et al., 2012).”
Bridel, C., van Wieringen, W. N., Zetterberg, H., Tijms, B. M., Teunissen, C. E., and the NFL Group, Alvarez-Cermeño, J. C., Andreasson, U., Axelsson, M., Bäckström, D. C., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.1534 · Cited by 764
Self-citationConsensus statement for diagnosis of subcortical small vessel disease
Rosenberg, G. A., Wallin, A., Wardlaw, J. M., Markus, H. S., Montaner, J., Wolfson, L., Iadecola, C., Zlokovic, B. V., Joutel, A., Dichgans, M., et al. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.172 · Cited by 221
“Sulfatide predicted progression of white-matter lesions over 3 years, which may reflect remyelination.(107) Separation of SVD from AD has been shown to be possible in studies of CSF biomarkers.”
BackgroundSelf-citationPhospholipids and Alzheimer’s Disease: Alterations, Mechanisms and Potential Biomarkers
Kosicek, M., & Hecimovic, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011310 · Cited by 214
The impact of cerebrovascular aging on vascular cognitive impairment and dementia
Yang, T., Sun, Y., Lu, Z., Leak, R. K., & Zhang, F. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.007 · Cited by 205
“In damaged WM, there may be compensatory attempts to remyelinate axons, but most of these efforts fail (Franklin and Ffrench-Constant, 2008; Jonsson et al., 2012).”
Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer’s Disease Diagnosis
Bjerke, M., & Engelborghs, S. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170680 · Cited by 132
Self-citationWallin, A., Kapaki, E., Boban, M., Engelborghs, S., Hermann, D. M., Huisa, B., Jonsson, M., Kramberger, M. G., Lossi, L., Malojcic, B., et al. (2017) · BMC Neurology · doi:10.1186/s12883-017-0877-3 · Cited by 89
“CSF sulfatide has also been shown to predict WML progression in nondisabled patients with WML [87].”
BackgroundSelf-citationGallart-Palau, X., Lee, B. S. T., Adav, S. S., Qian, J., Serra, A., Park, J. E., Lai, M. K. P., Chen, C. P., Kalaria, R. N., & Sze, S. K. (2016) · Molecular Brain · doi:10.1186/s13041-016-0205-7 · Cited by 70
“Impaired remyelination has previously been characterized to be associated with WM lesions [56], and may also be a feature of patients with AD + CVD, in whom the putative remyelination defect was closely associated with Gln deamidation of MBP.”
BackgroundVilar‐Bergua, A., Llena, I. R., Nafría, C., Bustamante, A., Llombart, V., Delgado, P., & Montaner, J. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.68 · Cited by 65
Wallin, A., Nordlund, A., Jonsson, M., Blennow, K., Zetterberg, H., Öhrfelt, A., Stålhammar, J., Eckerström, M., Carlsson, M., Olsson, E., et al. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.148 · Cited by 48
Self-citationBlomqvist, M., Zetterberg, H., Blennow, K., & Månsson, J. (2021) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2021.103670 · Cited by 50
“In a follow-up of the LADIS study, the authors showed that low levels of CSF sulfatide predicted the progression of white matter lesions (Jonsson et al., 2012).”
BackgroundSelf-citationde la Monte, S. M. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230555 · Cited by 32
Blomqvist, M., Borén, J., Zetterberg, H., Blennow, K., Månsson, J., & Ståhlman, M. (2017) · Journal of Lipid Research · doi:10.1194/jlr.d076588 · Cited by 18
Self-citationMagnetic resonance imaging features of leukoaraiosis in elderly dogs
Scarpante, E., Cherubini, G. B., Stefani, A. D., & Taeymans, O. (2017) · Veterinary Radiology & Ultrasound · doi:10.1111/vru.12489 · Cited by 16
Meng, T., Fei, Q., Lv, T., & Chen, S. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1517663 · Cited by 10
“NfL levels can reflect changes in white matter and subcortical axonal neurodegeneration (Jonsson et al., 2012).”
Andrén, E. A., Kettunen, P., Bjerke, M., Rolstad, S., Zetterberg, H., Blennow, K., Wallin, A., & Svensson, J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230680 · Cited by 6
Self-citationWang, Y., Nakajima, T., Diao, P., Yamada, Y., Nakamura, K., Nakayama, J., Tanaka, N., Aoyama, T., & Kamijo, Y. (2020) · The FASEB Journal · doi:10.1096/fj.202000030rr · Cited by 6
Svensson, J., Blomqvist, M., Kettunen, P., Eckerström, C., Henricsson, M., Jonsson, M. A. G., Bjerke, M., Månsson, J., & Wallin, A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201552 · Cited by 4
Self-citationNeuroimaging and laboratory aspects
Pantoni, L., & Gorelick, P. B. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139382694.012
Self-citationCerebral small vessel disease: cerebrospinal fluid aspects
Wallin, A., & Bjerke, M. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139382694.018
Self-citationSaleem, M. (2017) · TSpace (University of Toronto)
Metadata
- Authors
- Jonsson, M., Zetterberg, H., Rolstad, S., Edman, A., Gouw, A. A., Bjerke, M., Lind, K., Blennow, K., Pantoni, L., Inzitari, D., & Wallin, A.
- Affiliations
- University of Gothenburg (SE)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- University of Florence (IT)
- ORCID
- Venue
- Dementia and Geriatric Cognitive Disorders
- Publisher
- S. Karger AG
- Published
- 2012
- Volume
- 34
- Issue
- 1
- Pages
- 61-67
- ISSN
- 1420-8008 (ISSN-L)
- 1421-9824
- OpenAlex
- W2010431115
- Cited by
- 22
- References
- 38
- Citations by year
- 2025: 1 · 2023: 2 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 2 · 2013: 2
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Dementia and Geriatric Cognitive Disorders (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- white matter lesions, lesion progression, biomarkers, demyelination, remyelination, tau protein, neurofilament light subunit, CSF/serum albumin ratio, LADIS study, older adults
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Brain, Demyelinating Diseases, Female, Humans, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Male, Nerve Degeneration, Netherlands, Neuropsychological Tests, Predictive Value of Tests, Socioeconomic Factors, Sulfoglycosphingolipids, Dementia, Vascular, Biomarkers, Linear Models, Amyloid beta-Peptides, tau Proteins, Disease Progression, Leukoaraiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.